The doubters about Duffy can believe what they want to. I really don't care. But I do think it's hilarious the same people who would be so skeptical about whether he actually left will then - when they find out it's true - turn around and tell you his leaving is a good thing. It's beyond comical. "There's no way he left! Oh, he did? Well, then that's a good thing! It must mean the SAP is done!"
Yes, the company made a huge deal (their issuing a PR about anything is their way of saying it's a huge deal) about hiring him. And then they didn't say a word when he left seven months later. What a joke. Just like everything else with this company.
I think more and more people are coming around to the realization that everything I've been telling you for the last two years is true, and I think a lot more of you are going to be in that camp after this weekend. This whole thing has been waaaayyy over-complicated by those who choose to parse numbers and focus on meaningless details such as how many are still alive, daily anecdotes about Kat, how many are methylated and how many are unmethylated, and a smorgasbord of other meaningless interim data points. All of these things are great fun to talk about, but they don't mean anything. They are distractions. I can hear some of you right now screaming, "How can you say that the number of survivors is meaningless?" Well, that data point only has meaning if you can prove your product is the reason they are still alive. The only thing that means anything is whether they can prove it. That's how the process works, and that's what trials are for.
It seems increasingly obvious that, for whatever reason, they cannot prove it. It's a simple fact that if this trial had been successful they would have told us five or more years ago. But they didn't. That's really it, and that's really all you need to know. Instead they tried to change the whole direction of the trial thinking they could get the regulators to alter their rules to accommodate them. The CEO as much as admitted this in a recent response letter to the FDA. The worst part is that they never explained the strategy to shareholders or why they chose to do it - not once. Still, to this day, they have never explained it to shareholders. They've dropped hints about long tails and home runs, but they've never once actually explained to shareholders what in the hell they are doing. That's because if they were to explain it, they would have to admit that they know the trial likely failed, for whatever reason, to meet the endpoints it was set up to measure in the first place. Back when they found out this trial likely failed and they decided to not tell shareholders, not learn from their mistakes and start over, and instead go in a whole new direction, well, that's when this whole thing became nothing more than a scam. And that's where we are today. Maybe somebody should ask them about that tomorrow.
